These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2833487)

  • 1. Nomenclature of LY146032.
    Hamilton-Miller JM
    J Antimicrob Chemother; 1988 Jan; 21(1):133. PubMed ID: 2833487
    [No Abstract]   [Full Text] [Related]  

  • 2. In-vitro activity of LY146032 against Staphylococcus aureus and S. epidermidis.
    Coudron PE; Johnston JL; Archer GL
    J Antimicrob Chemother; 1987 Oct; 20(4):505-11. PubMed ID: 2824426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in-vitro activity of LY146032 a new peptolide, with vancomycin and eight other agents against gram-positive organisms.
    Benson CA; Beaudette F; Trenholm G
    J Antimicrob Chemother; 1987 Aug; 20(2):191-6. PubMed ID: 2822645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of LY146032 daptomycin and other agents against JK diphtheroids.
    Dealler SF
    J Antimicrob Chemother; 1988 Jun; 21(6):807-8. PubMed ID: 2842282
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococci.
    Andrew JH; Wale MC; Wale LJ; Greenwood D
    J Antimicrob Chemother; 1987 Aug; 20(2):213-21. PubMed ID: 2822649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin.
    Pohlod DJ; Saravolatz LD; Somerville MM
    J Antimicrob Chemother; 1987 Aug; 20(2):197-202. PubMed ID: 2822646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of LY146032 against Staphylococcus aureus, Listeria monocytogenes, Corynebacterium JK, and Bacillus spp., in comparison with various antibiotics.
    Van der Auwera P; Grenier P; Klastersky J
    J Antimicrob Chemother; 1987 Aug; 20(2):209-12. PubMed ID: 2822648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in-vitro activity of LY146032 and eight other antibiotics against gram-positive bacteria isolated from children.
    Kline MW; Mason EO; Kaplan SL; Lamberth LB; Johnson GS
    J Antimicrob Chemother; 1987 Aug; 20(2):203-7. PubMed ID: 2822647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activity of LY146032 against gram-positive isolates from cancer patients.
    Saito H; Rolston KV; Ho DH; LeBlanc B; Bodey GP
    J Antimicrob Chemother; 1987 Oct; 20(4):497-503. PubMed ID: 2824425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the investigational drug, LY146032, with vancomycin in experimental pneumonia due to methicillin-resistant Staphylococcus aureus.
    Kephart PA; Esposito AL
    J Antimicrob Chemother; 1988 Jan; 21(1):33-9. PubMed ID: 2833488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LY146032: activity and resistance development in vitro.
    Mouton RP; Mulders SL
    J Antimicrob Chemother; 1987 Oct; 20(4):513-7. PubMed ID: 2824427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nomenclature proposal for the octapeptin antibiotics.
    Meyers E; Parker WL; Brown WE
    J Antibiot (Tokyo); 1976 Nov; 29(11):1241-2. PubMed ID: 993110
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraphagocytic penetration of antibiotics.
    Van der Auwera P; Matsumoto T; Husson M
    J Antimicrob Chemother; 1988 Aug; 22(2):185-92. PubMed ID: 2846489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of LY146032 on human polymorphonuclear leucocytes in vitro.
    Van der Auwera P; Petrikkos G; Matsumoto T; Husson M
    J Antimicrob Chemother; 1988 Jan; 21(1):57-63. PubMed ID: 2833489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Round table on nomenclature of antibiotics.
    Antimicrob Agents Chemother (Bethesda); 1965; 5():1102-3. PubMed ID: 5883407
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the nomenclature of antibiotics].
    Vaksman ZA
    Antibiotiki; 1967 May; 12(5):430-1. PubMed ID: 5593968
    [No Abstract]   [Full Text] [Related]  

  • 17. A liaR deletion restores susceptibility to daptomycin and antimicrobial peptides in multidrug-resistant Enterococcus faecalis.
    Reyes J; Panesso D; Tran TT; Mishra NN; Cruz MR; Munita JM; Singh KV; Yeaman MR; Murray BE; Shamoo Y; Garsin D; Bayer AS; Arias CA
    J Infect Dis; 2015 Apr; 211(8):1317-25. PubMed ID: 25362197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for assigning names to antibiotics. The Committee on Nomenclature of Antibiotics. S. A. Waksman.
    Antonie Van Leeuwenhoek; 1966; 32(3):242-4. PubMed ID: 5296711
    [No Abstract]   [Full Text] [Related]  

  • 19. [Terminology used in the study of antibiotics (sensitivity, resistance, dependence)].
    HAUDUROY P; ROSSET W
    Ann Inst Pasteur (Paris); 1950 Mar; 78(3):414-5. PubMed ID: 15425920
    [No Abstract]   [Full Text] [Related]  

  • 20. [A definition of antibiotics].
    MASCHERPA P
    G Ital Chemioter; 1954; 1(1):213. PubMed ID: 13191629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.